Related Experiment Videos
Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801)
J Herrstedt1, B H Jeppesen, P Dombernowsky
1Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study.
Acta oncologica (Stockholm, Sweden)·2021
Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2018
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Planetary health and pharmacology: Addressing the ecological impact and circular threat of pharmaceuticals.
Ecotoxicology and environmental safety·2026
Prevalence of stimulant use among adolescents and young adults by pseudo-cohort and sex: evidence from a national survey.
The American journal of drug and alcohol abuse·2026
Adverse effect MonoPoly: Antipsychotic monopharmacy vs antipsychotic polypharmacy in the treatment of schizophrenia.
Indian journal of psychiatry·2026